After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...

Ipsen may be a recent entrant into the antibody-drug conjugate space, but the French biopharma is continuing to make up for lost time. The latest addition to the Paris-based company’s portfolio is ...

Reese Witherspoon and her three children are getting into the holiday spirit ahead of the Christmas holiday. The Legally Blonde star shared a post capturing the memories she had been making this ...

VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 3.47M Sep 30, 2025 3.02% 244,648,342 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 2.62M Sep 30, 2025 2.28% 184,953,023 COHEN & STEERS ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

The Food and Drug Administration has put a partial clinical hold on one of Merck & Co. and Daiichi Sankyo’s antibody-drug conjugates following an unexpected number of deaths in a late-stage clinical ...